Company news

NeoGenomics, Inc. news in 2025

NeoGenomics, Inc.'s news releases, calls and decks from 2025, newest first.

View company

NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. "Jack" Kenny to its Board of Directors

December 30, 2025

NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation

December 14, 2025

NeoGenomics to Present New ctDNA Research at SABCS 2025

December 9, 2025

NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025

December 7, 2025

NeoGenomics to Participate in Upcoming Investor Conferences

November 5, 2025

NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors

October 29, 2025

NeoGenomics Reports Third Quarter 2025 Results

October 27, 2025

NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025

October 13, 2025

NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025

October 6, 2025

Court Rules for NeoGenomics in Patent Infringement Lawsuit Against Natera

August 28, 2025

NeoGenomics Launches PanTracer LBx, Expanding Access to Comprehensive Genomic Profiling with Liquid Biopsy

July 29, 2025

NeoGenomics Reports Second Quarter 2025 Results

July 28, 2025

NeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025

June 30, 2025

NeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care

June 29, 2025

NeoGenomics Appoints Dr. Marjorie Green to Board of Directors

June 23, 2025

NeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025

May 27, 2025

NeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer

May 21, 2025

NeoGenomics to Participate in Upcoming June Investor Conferences

May 19, 2025

NeoGenomics Pays Off 1.25% Convertible Senior Notes

April 30, 2025

NeoGenomics Reports First Quarter 2025 Results

April 28, 2025

NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform

April 28, 2025

NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting

April 21, 2025

NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025

April 7, 2025

NeoGenomics Completes Acquisition of Pathline

April 6, 2025

Tony Zook Assumes Role as Chief Executive Officer of NeoGenomics

March 31, 2025

NeoGenomics Appoints Warren Stone as President & Chief Operating Officer

March 17, 2025

NeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline

March 9, 2025

NeoGenomics Reports Fourth Quarter and Full Year 2024 Results

February 17, 2025

PacBio Announces Appointment of Chris Smith to Board of Directors

January 29, 2025

NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025

January 28, 2025

NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan

January 14, 2025

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

January 13, 2025

NeoGenomics Announces Chief Executive Officer Succession

January 9, 2025

NeoGenomics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

January 5, 2025

Calls in 2025

Decks in 2025